DEXIS, a leader in dental imaging technologies, will be participating in the upcoming 2023 Greater New York Dental Meeting (GNYDM) to showcase its latest releases. The company is excited to present the DEXIS OP 3D LX and DEXassist Solution through hands-on demonstrations during the event.
One of the main attractions at the exhibition will be the opportunity for dental professionals to explore the DEXIS ORTHOPANTOMOGRAPH OP 3D LX firsthand. This cutting-edge device offers expanded 3D diagnostic capabilities, and attendees will have the chance to witness its innovative features up close. DEXIS solution experts will be available to provide live demonstrations of its key functionalities.
The OP 3D LX provides a comprehensive range of dental extraoral imaging options, including both 2D and 3D imaging. It also incorporates assisted intelligence (AI) features from DTX Studio Clinic, which streamline workflows and reduce time-consuming tasks, allowing clinicians to focus more on patient care.
In addition to the OP 3D LX, DEXIS will also be presenting the DEXassist Solution. This solution seamlessly integrates with existing DEXIS Imaging Suite Software and offers AI-enabled 2D findings for diagnosing patients and planning treatments. With just a simple click, clinicians can identify up to six different pathologies, saving valuable time. Moreover, doctors can easily share the AI findings with patients in a clear and understandable format.
Brian Gooch, Global Product Management and Marketing Vice President at DEXIS, highlights the company’s dedication to innovation and supporting dental practices. He emphasizes that both the OP 3D LX and DEXassist Solution showcase DEXIS’s unwavering commitment to innovation, improving practice productivity, and enhancing diagnostic confidence.
DEXIS invites attendees to visit their booth number 2306 during the event for live demonstrations of these state-of-the-art solutions and to discuss their specific dental practice needs and goals.
To learn more about DEXIS and its range of dental imaging technologies and solutions, please visit their official website at https://dexis.com/en-us/.
DEXIS has been a global leading brand in digital radiography for over 70 years. The company has brought together trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to offer a comprehensive digital diagnostic solution. DEXIS’s innovative technology enhances diagnostic capabilities, accelerates workflow, and simplifies treatment paths for better patient outcomes.
About Envista Holdings Corporation:
Envista is a global family of over 30 trusted dental brands, including DEXIS, Nobel Biocare, Ormco, and Kerr. Their shared purpose is to partner with professionals to improve lives by providing industry-leading dental consumables, solutions, technology, and services. With a comprehensive portfolio covering a wide range of clinical needs, Envista is dedicated to meeting the needs of dental professionals worldwide.